Further clinical study on anticataract effect of elaneer eyedrops and triphaladi capsule in immature cataract
Not Applicable
Completed
- Conditions
- Health Condition 1: null- Immature cataract
- Registration Number
- CTRI/2015/12/006427
- Lead Sponsor
- Institute for Post Graduate Teaching and Research in Ayurveda
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 100
Inclusion Criteria
Patients who meet the diagnostic standards of Immature Cataract
Exclusion Criteria
Subjects who are suffering from congenital Cataract, mature and hyper mature Cataract, Glaucoma, Diabetic Retinopathy,Hypertensive retinopathy, Macular degeneration, Retinitis pigmentosa, whose blood sugar and blood pressure are not within normal limits, who are under steroid treatment or any kind of Immunosuppressive therapy or under any Cataract inducing medications
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method grading of cataractous lens to assess changes in the area and density of lenticular opacity by Slit lamp Biomicroscopic examination in tangentional sectioning and retro illumination technique . <br/ ><br>Timepoint: 0, 12 weeks <br/ ><br>
- Secondary Outcome Measures
Name Time Method improvement in the subjective symptoms diplopia, polyopia, nyctalopia, hamarlopia, galre, coloured halos, floaters etc <br/ ><br>improvement in retinoscopy and auto refractometer readingsTimepoint: 0, 12 weeks